FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4210568827> ?p ?o ?g. }

• W4210568827 endingPage "25" @default.
• W4210568827 startingPage "17" @default.
• W4210568827 abstract "Background: Most data on the effect of inflammatory bowel disease (IBD) and its treatments on coronavirus disease 2019 (COVID-19) outcomes have not had non-IBD comparators. Hence, we aimed to describe COVID-19 outcomes in IBD compared to non-IBD patients. Methods: We conducted a prospective cohort study of registered IBD patients with confirmed COVID-19 from six provinces in Iran from February to April 2020. Proven COVID-19 patients were followed up at four weeks and the frequency of outcomes was assessed. Multivariable logistic regression was used to assess associations between demographics, clinical characteristics and COVID-19 outcomes. Results: Overall, 2159 IBD patients and 4721 household members were enrolled, with 84 (3.9%) and 49 (1.1%) participants having confirmed COVID-19, respectively. Household spread of COVID-19 was not common in this cohort (1.2%). While hospitalization was significantly more frequent in IBD patients compared with non-IBD household members (27.1% vs. 6.0%, P=0.002), there was no significant difference in the frequency of severe cases. Age and presence of IBD were positively associated with hospitalization in IBD compared with non-IBD household members (OR: 1.06, 95% CI: 1.03-1.10; OR: 5.7, 95% CI: 2.02– 16.07, respectively). Age, presence of new gastrointestinal symptoms, and 5-aminosalicylic acid (5-ASA) use were associated with higher hospitalization rate in IBD patients (OR: 1.13, 95% CI: 1.05–1.23; OR: 6.49, 95% CI: 1.87–22.54; OR: 6.22, 95% CI: 1.90–20.36, respectively). Anti-tumor necrosis factor (TNF) was not associated with more severe outcomes. Conclusion: Age, presence of new gastrointestinal symptoms and use of 5-ASA were associated with increased hospitalization rate among IBD patients, while anti-TNF therapy had no statistical association." @default.
• W4210568827 created "2022-02-08" @default.
• W4210568827 creator A5014214187 @default.
• W4210568827 creator A5015470174 @default.
• W4210568827 creator A5019778550 @default.
• W4210568827 creator A5020792446 @default.
• W4210568827 creator A5021188759 @default.
• W4210568827 creator A5022138504 @default.
• W4210568827 creator A5024561441 @default.
• W4210568827 creator A5028965717 @default.
• W4210568827 creator A5028997080 @default.
• W4210568827 creator A5032130532 @default.
• W4210568827 creator A5033087694 @default.
• W4210568827 creator A5040622493 @default.
• W4210568827 creator A5041182198 @default.
• W4210568827 creator A5041981029 @default.
• W4210568827 creator A5048493929 @default.
• W4210568827 creator A5049643927 @default.
• W4210568827 creator A5051197496 @default.
• W4210568827 creator A5051406372 @default.
• W4210568827 creator A5076916478 @default.
• W4210568827 creator A5077058925 @default.
• W4210568827 creator A5084265272 @default.
• W4210568827 creator A5084511527 @default.
• W4210568827 creator A5086697726 @default.
• W4210568827 creator A5089534855 @default.
• W4210568827 date "2022-01-01" @default.
• W4210568827 modified "2023-10-16" @default.
• W4210568827 title "Outcomes of COVID-19 in Patients with Inflammatory Bowel Disease: Comparison with Household Members and the Role of IBD Medications" @default.
• W4210568827 doi "https://doi.org/10.34172/aim.2022.04" @default.
• W4210568827 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35128908" @default.
• W4210568827 hasPublicationYear "2022" @default.
• W4210568827 type Work @default.
• W4210568827 citedByCount "3" @default.
• W4210568827 countsByYear W42105688272022 @default.
• W4210568827 crossrefType "journal-article" @default.
• W4210568827 hasAuthorship W4210568827A5014214187 @default.
• W4210568827 hasAuthorship W4210568827A5015470174 @default.
• W4210568827 hasAuthorship W4210568827A5019778550 @default.
• W4210568827 hasAuthorship W4210568827A5020792446 @default.
• W4210568827 hasAuthorship W4210568827A5021188759 @default.
• W4210568827 hasAuthorship W4210568827A5022138504 @default.
• W4210568827 hasAuthorship W4210568827A5024561441 @default.
• W4210568827 hasAuthorship W4210568827A5028965717 @default.
• W4210568827 hasAuthorship W4210568827A5028997080 @default.
• W4210568827 hasAuthorship W4210568827A5032130532 @default.
• W4210568827 hasAuthorship W4210568827A5033087694 @default.
• W4210568827 hasAuthorship W4210568827A5040622493 @default.
• W4210568827 hasAuthorship W4210568827A5041182198 @default.
• W4210568827 hasAuthorship W4210568827A5041981029 @default.
• W4210568827 hasAuthorship W4210568827A5048493929 @default.
• W4210568827 hasAuthorship W4210568827A5049643927 @default.
• W4210568827 hasAuthorship W4210568827A5051197496 @default.
• W4210568827 hasAuthorship W4210568827A5051406372 @default.
• W4210568827 hasAuthorship W4210568827A5076916478 @default.
• W4210568827 hasAuthorship W4210568827A5077058925 @default.
• W4210568827 hasAuthorship W4210568827A5084265272 @default.
• W4210568827 hasAuthorship W4210568827A5084511527 @default.
• W4210568827 hasAuthorship W4210568827A5086697726 @default.
• W4210568827 hasAuthorship W4210568827A5089534855 @default.
• W4210568827 hasBestOaLocation W42105688271 @default.
• W4210568827 hasConcept C126322002 @default.
• W4210568827 hasConcept C151956035 @default.
• W4210568827 hasConcept C188816634 @default.
• W4210568827 hasConcept C201903717 @default.
• W4210568827 hasConcept C2778260677 @default.
• W4210568827 hasConcept C2779134260 @default.
• W4210568827 hasConcept C2779280984 @default.
• W4210568827 hasConcept C2780479503 @default.
• W4210568827 hasConcept C30036603 @default.
• W4210568827 hasConcept C3008058167 @default.
• W4210568827 hasConcept C524204448 @default.
• W4210568827 hasConcept C71924100 @default.
• W4210568827 hasConcept C72563966 @default.
• W4210568827 hasConcept C90924648 @default.
• W4210568827 hasConceptScore W4210568827C126322002 @default.
• W4210568827 hasConceptScore W4210568827C151956035 @default.
• W4210568827 hasConceptScore W4210568827C188816634 @default.
• W4210568827 hasConceptScore W4210568827C201903717 @default.
• W4210568827 hasConceptScore W4210568827C2778260677 @default.
• W4210568827 hasConceptScore W4210568827C2779134260 @default.
• W4210568827 hasConceptScore W4210568827C2779280984 @default.
• W4210568827 hasConceptScore W4210568827C2780479503 @default.
• W4210568827 hasConceptScore W4210568827C30036603 @default.
• W4210568827 hasConceptScore W4210568827C3008058167 @default.
• W4210568827 hasConceptScore W4210568827C524204448 @default.
• W4210568827 hasConceptScore W4210568827C71924100 @default.
• W4210568827 hasConceptScore W4210568827C72563966 @default.
• W4210568827 hasConceptScore W4210568827C90924648 @default.
• W4210568827 hasIssue "1" @default.
• W4210568827 hasLocation W42105688271 @default.
• W4210568827 hasLocation W42105688272 @default.
• W4210568827 hasOpenAccess W4210568827 @default.
• W4210568827 hasPrimaryLocation W42105688271 @default.
• W4210568827 hasRelatedWork W1998231725 @default.
• W4210568827 hasRelatedWork W2070285775 @default.
• W4210568827 hasRelatedWork W2124908533 @default.
• W4210568827 hasRelatedWork W2258300052 @default.

• next